Market News / Story
Matricelf to Meet Investment Banks at NIBA's 153rd Investment Conference Ahead of Planned Nasdaq Dual Listing and First in Human Studies
ACCESS Newswire ·
ACCESS Newswire reports: Management seeks an investment banking partner for a potential follow on offering after its planned Nasdaq dual listing to support the Company's transition into first in human studies. NESS ZIONA, ISRAEL / ACCESS Newswire / October 6, 2026 / Matricelf Ltd. , a regenerative medicine company developing personalized, autologous engineered neural tissue for spinal cord injury, today announced that it will present at the National Investment Banking Association's 153rd…